Cannabidiol reduces seizures in children with severe epilepsy

“Seizures in Dravet syndrome are extremely difficult to control and they can be deadly,” says study co-author Linda Laux, MD, from Stanley Manne Children’s Research Institute at Ann Robert H. Lurie Children’s Hospital of Chicago. “Our results are encouraging, especially considering that we don’t have any antiepileptic drugs approved for Dravet syndrome in the U.S.”

The study included 120 children and young adults with Dravet syndrome and drug-resistant seizures. They were randomly assigned to receive either cannabidiol or a placebo, in addition to standard antiepileptic treatment.

Adverse events were reported in 93 percent of the patients taking cannabidiol, compared to 75 percent of the patients in the placebo group. The most common side effects were drowsiness, diarrhea and decreased appetite.

“We will need more data to determine the long-term efficacy and safety of cannabidiol for Dravet syndrome,” says Laux, who is the Medical Director of the Comprehensive Epilepsy Center at Lurie Children’s

... read more at: https://www.sciencedaily.com/releases/2017/05/170526085003.htm